argus

Biocon Ltd.

NSE: BIOCONINE376G0101365,391 Cr

Timeline

Time (IST)TypeMEventSrc
01 Jun, 08:29 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
21 May, 07:00 pmBiocon Limited has informed the Exchange about Reminder Letter to shareholders to claim unclaimed dividendsnse
14 May, 04:29 pmBiocon Limited has informed the Exchange about Transcriptnse
14 May, 04:27 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
11 May, 08:33 amBiocon Limited has informed the Exchange regarding 'Company Statement'.nse
09 May, 04:18 pmBiocon Limited has informed the Exchange about Copy of Newspaper Publication for Financial Resultsnse
08 May, 09:38 pmBiocon Limited has informed the Exchange about Link of Recordingnse
08 May, 09:31 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
08 May, 08:18 amBiocon Limited has informed the Exchange about Investor Presentationnse
08 May, 08:16 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
08 May, 12:06 amMonitoring Agency Reportnse
07 May, 11:46 pmBiocon Ltd - 532523 - Outcome Of Board Meeting_Change In Long Term Incentive Planbse
07 May, 11:44 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Issue of Securitiesbse
07 May, 11:42 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Acquisitionbse
07 May, 11:41 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sbse
07 May, 11:39 pmBiocon Ltd - 532523 - Outcome Of Board Meeting_Completion Of Tenure Of Statutory Auditorsbse
07 May, 11:38 pmBiocon Limited has informed the Exchange that Record date for the purpose of Dividend is 03-Jul-2026.nse
07 May, 11:37 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
07 May, 11:37 pmBiocon Limited has informed the Exchange regarding a press release dated May 07, 2026, titled "Biocon Q4FY26 Total Income at Rs 4,569 Cr EBITDA at Rs 1,073 Cr; Net Profit (before exceptional items) at Rs 179 Cr FY26 Total Income at Rs 17,270 Cr; EBITDA at Rs 3,798 Cr; Net Profit (before exceptional items) at Rs 436 Cr".nse
07 May, 11:35 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Managementbse
07 May, 11:35 pmBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on May 07, 2026.nse
07 May, 11:34 pmBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on May 07, 2026-Acquisitionnse
07 May, 11:33 pmBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on May 07, 2026.nse
07 May, 11:32 pmBiocon Limited has informed the Exchange regarding Change in Auditors of the company.nse
07 May, 11:32 pmBiocon Ltd - 532523 - Corporate Action-Board approves Dividendbse
07 May, 11:31 pmBiocon Limited has informed the Exchange that Board of Directors at its meeting held on May 07, 2026, recommended Final Dividend of Rs. 0.5 per equity share.nse
07 May, 11:30 pmBiocon Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
07 May, 11:30 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
07 May, 11:23 pmBiocon Ltd - 532523 - Outcome Of Board Meeting-Financial Resultsbse
06 May, 09:52 pmBiocon Ltd - 532523 - Rumour Verificationbse
06 May, 09:38 pmThe Exchange has sought clarification from Biocon Limited with respect to recent news item captioned Biocon s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report. The response from the Company is attached.nse
06 May, 09:33 pmBiocon Limited has informed the Exchange about Rumour Verification - Regulation 30(11)nse
06 May, 12:53 pmThe Exchange has sought clarification from Biocon Limited with respect to recent news item captioned Biocon s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report. The response from the Company is awaited.nse
04 May, 06:11 pmBiocon Ltd - 532523 - Update on board meetingbse
30 Apr, 08:27 amBiocon Limited has informed the Exchange regarding 'Company Statement'.nse
29 Apr, 07:42 pmBiocon Ltd - 532523 - Certificate Pursuant To SEBI Master Circular No. SEBI/HO/DDHS/DDHS-Pod/P/CIR/2025/0000000137 Dated October 15, 2025bse
23 Apr, 07:41 pmBiocon Ltd - 532523 - Board Meeting Intimation for Intimation Of The Board Meeting And Earnings Conference Call For Analysts And Investorsbse
21 Apr, 08:48 amBiocon Limited has informed the Exchange regarding a press release dated April 21, 2026, titled "Biocon Receives Health Canada Approval of Bosaya (Denosumab) and Vevzuo (Denosumab), Biosimilars to Prolia® and Xgeva®".nse
21 Apr, 08:44 amBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
20 Apr, 08:31 pmBiocon Limited has informed the Exchange about "Reminder Letter to shareholders holding shares in physical form for furnishing of KYC details"nse
08 Apr, 08:40 amBiocon Limited has informed the Exchange regarding 'Company Statement'.nse
07 Apr, 04:07 pmBiocon Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Biocon Announces U.S. Commercial Launch of Bosaya and Aukelso , Denosumab Biosimilars".nse
07 Apr, 04:03 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
30 Mar, 01:11 pmBiocon Limited has informed the Exchange regarding 'Intimation of change in name of step-down subsidiary of the Company'.nse
27 Mar, 12:17 pmBiocon Limited has informed the Exchange regarding 'Amendment in Trust Deed'.nse
27 Mar, 12:07 pmBiocon Limited has informed the Exchange regarding a press release dated March 27, 2026, titled "Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026".nse
27 Mar, 12:05 pmBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026 - Key Managerial Personnels who are authorized to determine materiality of an event or information and make necessary disclosures to the Stock Exchange(s) pursuant to Regulation 30 of SEBI Listing Regulationsnse
27 Mar, 12:03 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
27 Mar, 12:03 pmBiocon Limited has informed the Exchange regarding Outcome of Board Meeting held on March 27, 2026 - Change in KMP and SMPnse
27 Mar, 12:01 pmBiocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Change in Managementbse